Rafferty Asset Management, LLC
Q4 2022 13F-HR Holdings
Net value change ($000)
+2,548,273
(27.1%)
New positions
45
Sold out positions
62
Turnover %
1.3%
Sector allocation + QoQ delta (equities-only)
Snapshot: Change Analysis
Compared to Q3 2022
Methodology:
sector metrics are equities-only;
instrument mix chart is ex-options;
options exposure is shown separately.
Why this matters.
Top Adds (Value $000, Stocks/ETFs)
| TLT | 283,627 | 115.9% |
| FXI | 91,733 | 50.3% |
| IWM | 73,497 | 11.2% |
| NVDA | 69,892 | 35.0% |
| AVGO | 64,324 | 29.3% |
| MSFT | 58,676 | 24.4% |
| KWEB | 56,763 | 52.8% |
| AAPL | 52,555 | 20.6% |
| BRK-B | 48,814 | 29.5% |
| JPM | 46,221 | 43.9% |
Top Reduces (Value $000, Stocks/ETFs)
| WOLF | -11,283 | -25.4% |
| CONTINENTAL RESOURCES, INC | -7,533 | -100.0% |
| TEAM | -7,296 | -100.0% |
| Global Blood Therapeutics, Inc. | -6,973 | -100.0% |
| ChemoCentryx, Inc. | -6,953 | -100.0% |
| Biohaven Pharmaceutical Holding Co Ltd. | -6,939 | -100.0% |
| BIDU | -6,393 | -100.0% |
| NTES | -6,151 | -100.0% |
| DOCU | -5,843 | -68.4% |
| VRSN | -5,745 | -64.9% |
Instrument mix + QoQ Δ (ex-options)
How this table is calculated:
SEC
VALUE ($000) is used as reported.
For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received.
Column % is bucket-based:
non-options share is calculated inside non-option total, options share is calculated inside options total.
Details.
Filter:
Instrument:
| Issuer Name | Ticker | Sector | Industry | Class | History | Value ($000) | % | Shares | Shares Δ | Shares Δ% | Value Δ ($000) | Value Δ% | Principal | Option Type |
|---|